SCHEMBL9049849

SCHEMBL9049849

N#C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC1=Cc2ccccc2C1

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PREP P48147 6/20 0.72
DPP4 P27487 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9049853 1.00 PREP (0.72) PREPDPP4
SCHEMBL9047257 0.91 PREP (0.62) PREPDPP4
SCHEMBL9047244 0.91 PREP (0.62) PREPDPP4
SCHEMBL9047756 0.89 PREP (0.65) PREPDPP4
SCHEMBL9047762 0.89 PREP (0.65) PREPDPP4
SCHEMBL7295355 0.85 PREP (0.78) PREP
SCHEMBL7298779 0.84 PREP (1.00) PREP
SCHEMBL7301847 0.84 PREP (1.00) PREP
SCHEMBL7294462 0.83 PREP (0.75) PREP
SCHEMBL7294125 0.83 PREP (0.75) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed